Axinn Counsel Rebecca Clegg Named 2025 MCCA Rising Star

Incisive. Inclusive. Invested. We’re Axinn.

Experienced, tenacious, and always trial-ready, we are committed to understanding complex legal challenges that impact the future of our clients’ businesses, globally.

Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.

With a strong culture of diversity, equity, and inclusion, we build relationships with our clients and colleagues alike, helping communities and acting with purpose. Our client service, entrepreneurialism, and inquisitive nature sit at the heart of the firm, enabling us to prioritize client goals and achieve successful outcomes.

Explore Firm Details

Axinn counsel Rebecca Clegg has been named a Rising Star for 2025 by the Minority Corporate Counsel Association (MCCA).

United States

Axinn counsel Rebecca Clegg has been named a Rising Star for 2025 by the Minority Corporate Counsel Association (MCCA). MCCA's Rising Stars is an annual list recognizing attorneys for their professional achievements and commitment to the legal profession and their communities. This year's Rising Stars will be honored at the 2025 Pathways Conference on September 9.

Rebecca's practice focuses on complex intellectual property litigation and counseling, particularly in the fields of medical devices, pharmaceuticals, biotechnology, and semiconductors. Rebecca regularly litigates medical device and Hatch-Waxman Paragraph IV patent infringement suits.

Contributor

Incisive. Inclusive. Invested. We’re Axinn.

Experienced, tenacious, and always trial-ready, we are committed to understanding complex legal challenges that impact the future of our clients’ businesses, globally.

Explore Firm Details

See More Popular Content From